BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17525734)

  • 1. p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity.
    Di Stefano P; Damiano L; Cabodi S; Aramu S; Tordella L; Praduroux A; Piva R; Cavallo F; Forni G; Silengo L; Tarone G; Turco E; Defilippi P
    EMBO J; 2007 Jun; 26(12):2843-55. PubMed ID: 17525734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation.
    Damiano L; Di Stefano P; Camacho Leal MP; Barba M; Mainiero F; Cabodi S; Tordella L; Sapino A; Castellano I; Canel M; Frame M; Turco E; Defilippi P
    Oncogene; 2010 Jun; 29(25):3677-90. PubMed ID: 20453886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of p140Cap phosphorylation sites: the EPLYA and EGLYA motifs have a key role in tyrosine phosphorylation and Csk binding, and are substrates of the Abl kinase.
    Repetto D; Aramu S; Boeri Erba E; Sharma N; Grasso S; Russo I; Jensen ON; Cabodi S; Turco E; Di Stefano P; Defilippi P
    PLoS One; 2013; 8(1):e54931. PubMed ID: 23383002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src.
    Sabe H; Hata A; Okada M; Nakagawa H; Hanafusa H
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3984-8. PubMed ID: 7513429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation.
    Zrihan-Licht S; Deng B; Yarden Y; McShan G; Keydar I; Avraham H
    J Biol Chem; 1998 Feb; 273(7):4065-72. PubMed ID: 9461599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SHP-2 binds to caveolin-1 and regulates Src activity via competitive inhibition of CSK in response to H2O2 in astrocytes.
    Jo A; Park H; Lee SH; Ahn SH; Kim HJ; Park EM; Choi YH
    PLoS One; 2014; 9(3):e91582. PubMed ID: 24632723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced C-terminal Src kinase activity is correlated inversely with pp60(c-src) activity in colorectal carcinoma.
    Cam WR; Masaki T; Shiratori Y; Kato N; Ikenoue T; Okamoto M; Igarashi K; Sano T; Omata M
    Cancer; 2001 Jul; 92(1):61-70. PubMed ID: 11443610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of C-terminal Src kinase homologous kinase suppresses activation of Lyn tyrosine kinase required for VLA5-mediated Dami cell spreading.
    Hirao A; Huang XL; Suda T; Yamaguchi N
    J Biol Chem; 1998 Apr; 273(16):10004-10. PubMed ID: 9545346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of C-terminal src kinase in human colorectal cancer cell lines.
    Watanabe N; Matsuda S; Kuramochi S; Tsuzuku J; Yamamoto T; Endo K
    Jpn J Clin Oncol; 1995 Feb; 25(1):5-9. PubMed ID: 7533218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal Src kinase-mediated EPIYA phosphorylation of Pragmin creates a feed-forward C-terminal Src kinase activation loop that promotes cell motility.
    Senda Y; Murata-Kamiya N; Hatakeyama M
    Cancer Sci; 2016 Jul; 107(7):972-80. PubMed ID: 27116701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of two regions in the p140Cap adaptor protein that retain the ability to suppress tumor cell properties.
    Sharma N; Repetto D; Aramu S; Grasso S; Russo I; Fiorentino A; Mello-Grand M; Cabodi S; Singh V; Chiorino G; Turco E; Stefano PD; Defilippi P
    Am J Cancer Res; 2013; 3(3):290-301. PubMed ID: 23841028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
    Je DW; O YM; Ji YG; Cho Y; Lee DH
    Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Src family kinases in the developing rat brain: correlation with their regulator kinase, Csk.
    Inomata M; Takayama Y; Kiyama H; Nada S; Okada M; Nakagawa H
    J Biochem; 1994 Aug; 116(2):386-92. PubMed ID: 7529760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-terminal Src kinase (CSK) modulates insulin-like growth factor-I signaling through Src in 3T3-L1 differentiation.
    Sekimoto H; Boney CM
    Endocrinology; 2003 Jun; 144(6):2546-52. PubMed ID: 12746317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
    McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
    Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
    Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
    Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton.
    Obergfell A; Eto K; Mocsai A; Buensuceso C; Moores SL; Brugge JS; Lowell CA; Shattil SJ
    J Cell Biol; 2002 Apr; 157(2):265-75. PubMed ID: 11940607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.